MGRM
Price:
$2.59
Market Cap:
$88.87M
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is h...[Read more]
Industry
Medical - Devices
IPO Date
2023-05-18
Stock Exchange
NASDAQ
Ticker
MGRM
According to Monogram Orthopaedics, Inc.’s latest financial reports and current stock price. The company's current ROE is -130.89%. This represents a change of 272.08% compared to the average of -35.18% of the last 4 quarters.
The mean historical ROE of Monogram Orthopaedics, Inc. over the last ten years is -21.30%. The current -130.89% ROE has changed 514.56% with respect to the historical average. Over the past ten years (40 quarters), MGRM's ROE was at its highest in in the September 2019 quarter at 214.96%. The ROE was at its lowest in in the March 2023 quarter at -478.97%.
Average
-21.30%
Median
-102.60%
Minimum
-337.27%
Maximum
654.06%
Discovering the peaks and valleys of Monogram Orthopaedics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.18%
Maximum Annual ROE = 654.06%
Minimum Annual Increase = -127.79%
Minimum Annual ROE = -337.27%
Year | ROE | Change |
---|---|---|
2023 | -102.60% | -68.91% |
2022 | -329.97% | -2.16% |
2021 | -337.27% | 85.57% |
2020 | -181.74% | -127.79% |
2019 | 654.06% | 1.18% |
2018 | 51.20% | -47.33% |
The current ROE of Monogram Orthopaedics, Inc. (MGRM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-256.61%
5-year avg
-59.50%
10-year avg
-21.30%
Monogram Orthopaedics, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Monogram Orthopaedics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Monogram Orthopaedics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Monogram Orthopaedics, Inc.'s ROE?
How is the ROE calculated for Monogram Orthopaedics, Inc. (MGRM)?
What is the highest ROE for Monogram Orthopaedics, Inc. (MGRM)?
What is the 3-year average ROE for Monogram Orthopaedics, Inc. (MGRM)?
What is the 5-year average ROE for Monogram Orthopaedics, Inc. (MGRM)?
How does the current ROE for Monogram Orthopaedics, Inc. (MGRM) compare to its historical average?